Vanguard Group Inc. Grows Holdings in M.D.C. Holdings, Inc. (NYSE:MDC)

Vanguard Group Inc. grew its stake in M.D.C. Holdings, Inc. (NYSE:MDC) by 1.6% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 6,984,701 shares of the construction company’s stock after acquiring an additional 109,539 shares during the period. Vanguard Group Inc. owned about 9.36% of M.D.C. worth $287,979,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Ronald Blue Trust Inc. raised its stake in shares of M.D.C. by 100.0% in the 3rd quarter. Ronald Blue Trust Inc. now owns 640 shares of the construction company’s stock valued at $26,000 after acquiring an additional 320 shares during the period. Stifel Financial Corp raised its stake in shares of M.D.C. by 2.9% in the 3rd quarter. Stifel Financial Corp now owns 12,100 shares of the construction company’s stock valued at $499,000 after acquiring an additional 344 shares during the period. CWM LLC raised its stake in shares of M.D.C. by 31.7% in the 3rd quarter. CWM LLC now owns 1,447 shares of the construction company’s stock valued at $60,000 after acquiring an additional 348 shares during the period. Ameritas Investment Partners Inc. raised its stake in shares of M.D.C. by 8.2% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,852 shares of the construction company’s stock valued at $227,000 after acquiring an additional 368 shares during the period. Finally, Allspring Global Investments Holdings LLC increased its stake in M.D.C. by 20.4% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,331 shares of the construction company’s stock worth $96,000 after buying an additional 395 shares during the period. 88.08% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at M.D.C.

In other news, Director David E. Blackford sold 6,200 shares of the company’s stock in a transaction on Monday, March 11th. The shares were sold at an average price of $62.69, for a total value of $388,678.00. Following the completion of the transaction, the director now owns 13,534 shares in the company, valued at approximately $848,446.46. The sale was disclosed in a document filed with the SEC, which is available at this link. Insiders own 23.30% of the company’s stock.

M.D.C. Trading Up 0.0 %

Shares of NYSE:MDC opened at $62.90 on Friday. M.D.C. Holdings, Inc. has a 52 week low of $36.47 and a 52 week high of $63.00. The company’s 50 day moving average is $62.62 and its two-hundred day moving average is $51.56. The company has a current ratio of 9.76, a quick ratio of 3.92 and a debt-to-equity ratio of 0.50. The company has a market cap of $4.72 billion, a PE ratio of 11.91 and a beta of 1.54.

M.D.C. (NYSE:MDC) last announced its quarterly earnings data on Tuesday, January 30th. The construction company reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.50 by $0.06. M.D.C. had a net margin of 8.64% and a return on equity of 12.32%. The company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.29 billion. During the same period in the prior year, the firm posted $1.08 EPS. The company’s quarterly revenue was down 11.9% compared to the same quarter last year. Equities analysts predict that M.D.C. Holdings, Inc. will post 5.38 earnings per share for the current fiscal year.

M.D.C. Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 21st. Shareholders of record on Wednesday, February 7th were given a $0.55 dividend. This represents a $2.20 dividend on an annualized basis and a dividend yield of 3.50%. The ex-dividend date of this dividend was Tuesday, February 6th. M.D.C.’s dividend payout ratio is presently 41.67%.

Wall Street Analysts Forecast Growth

MDC has been the topic of several recent research reports. StockNews.com initiated coverage on shares of M.D.C. in a research note on Tuesday. They set a “hold” rating on the stock. Evercore ISI downgraded shares of M.D.C. from an “outperform” rating to an “in-line” rating and upped their target price for the stock from $57.00 to $63.00 in a research note on Wednesday, January 31st. Finally, Raymond James reaffirmed a “market perform” rating on shares of M.D.C. in a research note on Wednesday, February 7th. One research analyst has rated the stock with a sell rating and five have given a hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $52.13.

About M.D.C.

M.DC Holdings, Inc, through its subsidiaries, engages in the homebuilding and financial service businesses. Its homebuilding operations include purchasing finished lots or developing lots for the construction and sale primarily of single-family detached homes to first-time and first-time move-up homebuyers under the Richmond American Homes name.